Prosecutors are undervalued, underpaid and overworked, says FDA responding to CJI NI report
The FDA has responded to a new report from the Criminal Justice Inspection Northern Ireland (CJI NI) into management and performance of the Public Prosecution Service (PPSNI).
FDA National Officer for Northern Ireland Robert Murtagh said the union welcomed the report, which made it clear that “reward and recognition are an outstanding issue with career progression for public prosecutors in NI lagging behind counterparts in the rest of the UK”.
Murtagh added that “Public Prosecutors in NI face significant challenges, including increasing processing times particularly in Crown Court cases, due to backlogs, longer decision times and court adjournments.
“The CJI NI has recognised the increasing complexity of cases being sent to the PPS, compounded by recent legislative changes and use of multi-media evidence that has, in part, led to longer decision times. It also highlights the reliance on external counsel and temporary agency staff with lower staff morale and high levels of sickness absence.”
The National Officer called for measures to be taken to address the issues identified in the report’s findings, saying, “We’ve long argued that our members are undervalued, underpaid and overworked, which is supported by the findings of this independent report.
“The FDA welcomes this report from the CJI NI and the Director of Public Prosecution’s commitment to longer-term strategic workforce planning.
“This work must be underpinned by a commitment to ensure public prosecutors in NI are rewarded and have progression pathways similar to colleagues in other prosecuting authorities in the UK as well as an increased recruitment of prosecutors to relieve workload pressures and reduce processing times.
“The Department of Finance and the wider Executive must recognise that investment in the PPS and our Public Prosecutors is vital to transforming the criminal justice system, reducing processing times and deliver for the needs of victims.”
Latest news
-
FDA responds to NICS decision not to participate in Belfast Pride 2026
The FDA’s National Officer for Northern Ireland Robert Murtagh has responded to the NICS decision not to take part in Belfast Pride 2026.
-
FDA tells NICS inquiry – “you cannot separate the performance and culture of the civil service from the political and governance environment in which it operates”
The FDA’s National Officer for Northern Ireland Robert Murtaugh gave oral evidence to NI Assembly Finance Committee as part of their inquiry into the performance and culture of the NICS.
-
FDA response to the Minister for Education’s written ministerial statement
FDA National Officer for Northern Ireland comments on the written ministerial statement made by Minister for Education Paul Givan this afternoon.
